{"schema":"hottub-news/story/v1","story":"st_hu36rnwnifxecvskjija","title":"AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/astrazeneca-merck-novo-deals-boost-chinese-biotech-as-global-interest-hu36rnwnif","count":1,"items":[{"id":"n_hu36rnwnifxecvskjija","seq":632564,"kind":"article","title":"AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows","url":"https://www.scmp.com/business/china-business/article/3369187/astrazeneca-merck-novo-deals-boost-chinese-biotech-global-interest-grows","summary":"Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop and commercialise Akeso’s immunotherapy drug ivonescimab outside China. Summit…","published":"2026-09-29T09:00:07Z","seen":"2026-09-29T09:45:53Z","lang":"en","source":{"id":"kite-scmp-com-62b166","name":"scmp.com","domain":"scmp.com","outlet":{"wikidata":"Q1198574","name":"South China Morning Post","type":"newspaper","country":"CN","designations":["daily newspaper","online newspaper"]}},"via":"kite-scmp-com-62b166","topics":["asia"],"authors":["author","Xinmei Shen"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q96472579","name":"Merck","type":"org"},{"id":"Q818846","name":"Novo","type":"org"}],"image":"https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/09/29/7f6c4329-d288-4727-beb9-619f8c34c411_3c3f6fa8.jpg?itok=z4ByUngy&v=1790670041","mentions":2,"story":"st_hu36rnwnifxecvskjija","category":"economy-business","category_p":0.7900000214576721,"sentiment":"positive","tone":0.7799999713897705,"political":0.15000000596046448}]}